|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| (11) | Number of the document | 2528945 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11701735.0 |
| Date of filing the European patent application | 2011-01-28 | |
| (97) | Date of publication of the European application | 2012-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
| (46) | Date of publication of the claims translation | 2017-01-25 |
| (86) | Number | PCT/US2011/022817 |
| Date | 2011-01-28 |
| (87) | Number | WO 2011/094467 |
| Date | 2011-08-04 |
| (30) | Number | Date | Country code |
| 299801 P | 2010-01-29 | US | |
| 361687 P | 2010-07-06 | US | |
| 388697 P | 2010-10-01 | US |
| (72) |
SKOKOS, Dimitris, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Diabeto gydymo su DLL4 antagonistais būdas |
| METHODS OF TREATING DIABETES WITH DLL4 ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2017-12-18 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-01-28 |